Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-20 Sale | 2024-05-22 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 16,128 | $6.45 | $104,026 | 413,719 (Direct) | View |
| 2024-02-12 Sale | 2024-02-14 8:53 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 38,618 | $15.24 | $588,538 | 422,125 (Direct) | View |
| 2023-05-22 Sale | 2023-05-24 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 10,324 | $10.12 | $104,479 | 321,131 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:21 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 19,322 | $11.36 | $219,479 | 261,586 (Direct) | View |
| 2022-05-23 Sale | 2022-05-25 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 10,583 | $11.5 | $121,705 | 266,245 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 4:01 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 17,607 | $10.77 | $189,627 | 195,380 (Direct) | View |
| 2021-11-23 Sale | 2021-11-24 4:08 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 13,776 | $11.58 | $159,526 | 183,661 (Direct) | View |
| 2021-05-24 Sale | 2021-05-26 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 2,077 | $12.25 | $25,443 | 197,437 (Direct) | View |
| 2021-02-26 Sale | 2021-03-02 4:44 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 4,439 | $9.11 | $40,439 | 160,859 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 34,936 | $0 | 429,847 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:53 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 81,641 | $0 | 422,125 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 57,971 | $0 | 379,102 (Direct) | View |
| 2023-03-08 Option Award | 2023-03-10 5:13 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 104,804 | $0 | 366,390 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 14,663 | $0 | 280,908 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 81,448 | $0 | 276,828 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 5:56 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO,SVP,Head-Res&Drug | 29,326 | $0 | 212,987 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 5:09 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 38,655 | $0 | 199,514 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 4:17 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 58,252 | $0 | 165,298 (Direct) | View |
| 2020-04-24 Option Award | 2020-04-28 4:03 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 20,740 | $0 | 107,046 (Direct) | View |
Ownership | 2020-04-21 4:31 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Shetzline Michael CMO, SVP & Head of Drug Devt. | 0 | $0 | 179,004 (Direct) | View |